Extreme Movers: Gemini 3 Pro's picks for 2026-10-30
Gemini 3 Pro picked ADT, GKOS, CROX, NOW, FTNT for a 1-day horizon. Average directional return: -1.08%. Directions called correctly: 40%.
| Experiment | Extreme Movers |
|---|---|
| Model | Gemini 3 Pro |
| Prompt version | extreme-movers-v11 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-10-30 |
| Measured to | 2026-11-02 |
| Benchmark | SPY |
| Status | Settled |
| Average directional return | -1.08% |
| Directions called correctly | 40% |
| Benchmark return | -0.09% |
The picks
| Rank | Symbol | Direction | Price change | Return in the called direction | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|---|---|
| 1 | ADT | up | +0.05% | +0.05% | 85% | +0.14% | Yes |
| 2 | GKOS | up | -0.30% | -0.30% | 75% | -0.21% | No |
| 3 | CROX | up | +0.50% | +0.50% | 70% | +0.59% | Yes |
| 4 | NOW | up | -0.86% | -0.86% | 65% | -0.77% | No |
| 5 | FTNT | up | -4.78% | -4.78% | 60% | -4.69% | No |
The model's market view
US equity markets exhibit bifurcated dynamics entering late October 2026. Disappointment over major technology earnings and aggressive capital expenditure budgets continues to weigh heavily on megacap indices like the NASDAQ, triggering acute sell-offs in software and megacap tech. Conversely, M&A announcements and strong consumer/healthcare earnings are generating massive upside momentum in select medium-to-large capitalisation equities. For the target session, single-stock momentum strategies are expected to diverge based on catalyst durability—acquisition announcements and major earnings beats/guidance upgrades are poised to maintain continuation, while extreme earnings-driven oversold reactions in established high-margin tech leaders are prime candidates for mean-reversion buying.
Why each pick
ADT
ADT spiked +33.31% in the source session following an official announcement that it agreed to be acquired by Thrive Holdings in a $15.3 billion transaction ($10.00 per share cash consideration). Because definitive cash acquisition announcements anchor equity valuations directly to the offer price, the initial jump represents a fundamental structural re-rating rather than a temporary speculative pump. The hypothesis is continuation toward the $10.00 deal value, as arb desks absorb remaining float. Reference price taken from live pre-market / delayed quote on October 30, 2026 ($9.89). Primary risk is unexpected regulatory intervention, which is minimal for home security.
GKOS
Glaukos Corporation rallied +32.84% during the source session after reporting blowout earnings results and raising full-year revenue guidance across its ophthalmic portfolio. Catalyst is substantive due to expanding gross margins and accelerating adoption of its iStent and iDose platforms. Given the sheer scale of institutional accumulation and earnings revisions, momentum is forecasted to continue upward into the target session as sell-side analysts issue follow-on price target upgrades. Reference price sourced from live quote data on October 30, 2026 ($241.07). Main risk is broader healthcare sector profit-taking.
CROX
Crocs Inc. jumped +25.20% in the source session after reporting strong Q3 results ($3.69 EPS vs. $3.31 consensus) and delivering its third consecutive full-year top- and bottom-line guidance raise driven by a return to growth in its HEYDUDE brand (+6% YoY). Catalyst is highly substantive. Such comprehensive operational beats and guidance hikes typically prompt multi-day institutional buying and price target increases. Hypothesis is continuation for direction up. Reference price fetched from current quote on October 30, 2026 ($149.74). Risk includes discretionary consumer weakness.
NOW
ServiceNow plunged -26.70% in the source session amid a macro-driven software sector drawdown triggered by earnings missteps and broader AI spending caution. The market reaction was severely exaggerated relative to the company's core subscription renewal rates and long-term enterprise software retention. The hypothesis is reversal (direction up relative to the steep drop), as institutional value investors step in to buy the overextended discount on a high-quality SaaS giant. Reference price verified on October 30, 2026 ($109.78). Primary risk is continued tech sector momentum selling.
FTNT
Fortinet declined -20.85% in the source session post-earnings despite solid revenue growth, as investors reacted negatively to conservative forward billings commentary. The catalyst is mix of substantive guidance adjustments and speculative market overreaction. Because cybersecurity remains a non-discretionary corporate budget priority and Fortinet maintains robust 38%+ operating margins, the drop is considered overextended. Hypothesis is reversal (direction up) for a technical dead-cat bounce and fundamental mean-reversion. Reference price sourced as of October 30, 2026 ($137.10). Risk is further sell-side downgrades.
Other models on the same run
| Model | Picks | Average directional return | Directions called correctly |
|---|---|---|---|
| Grok 4.7 | GKOS, CVNA, GEN, NOW, FTNT | +3.64% | 80% |
| Perplexity | INTC, RDDT, TWLO, REGN, AN | +2.02% | 80% |
| Muse Spark 1.1 | NOW, GKOS, ADT, CROX, IOVA | -0.72% | 80% |
| Claude Opus 5.5 | GOOGL, NOW, HII, TXT, CVNA | +1.38% | 60% |
| DeepSeek | ADT, GEN, CVNA, GOOGL, NCLH | -1.63% | 40% |
| GPT-6 | GKOS, ALNY, CROX, FTNT, NOW | +3.07% | 60% |
Written up on ForecastNest Insights: Extreme Movers: Gemini 3 Pro's picks for 2026-10-30.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.